Abstract
Objective: The aim of this work was to find obesity control method without rebound. In our previous studies, gymnemate extracted from Gymnema sylvestre, inhibited oleic acid absorption. The Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a genetic multifactor syndrome model, exhibits progressive overweight, hyperlipidemia and hyperglycemia. The effect of gymnemate on obesity in OLETF was investigated. Methods: Three groups were divided (n = 4–8): (1) OLETF-gymnemate, gymnema water extract (containing gymnemate) diet (62.5 g/kg) and water (2.5 g/kg) were supplied 2 weeks from 26–28 weeks, following it general diet and water were fed 3 weeks to observe if it rebound, (2) OLETF-control and (3) the counterpart Long-Evans Tokushima Otsuka rats as normal-control. Results: With gymnemate treatment, the food and water intake were decreased about 1/3 and 2/3, along with body weight reduced 57.2± 6.4 and 75.5± 6.3 g during 1 and 2 weeks respectively. In the end of experiment (3 weeks after gymnemate withdrawal), the body weight was decreased to no significant difference with normal-control. The total cholesterol was decreased about 1/3, moreover LDL+VLDL (low-density and very-low-density lipoprotein) cholesterol decreased about 1/2. The proportion of HDL (high-density lipoprotein) cholesterol to the total cholesterol was increased. The serum triglyceride was decreased to the 1/4 of OLETF control. The level of serum cholesterol and triglyceride was no significant difference in gymnemate group with normal group. Conclusion: Supplementation with gymnemate promotled weight loss by its ability to reduce hyperlipidemia, which was no withdrawal rebound: an important discovery. Supplementation with gymnemate is a novel therapeutic tool for weight management, especially in multifactor syndrome.
Similar content being viewed by others
References
Ozsahin AK, Gokcel A, Sezgin N, Akbaba M, Guvener N, Ozisik L, Karademir BM.: Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 17: 230–234, 2004
Daskalopoulou SS, Mikhailidis DP, Elisaf M: Prevention and treatment of the metabolic syndrome. Angiology 55: 589–612, 2004
Hexeberg S, Retterstol K: Hypertriglyceridemia – diagnostics, risk and treatment. Tidsskr Nor Laegeforen 124: 2746–9, 2004
Moon YS, Kashyap ML: Pharmacologic treatment of type 2 diabetic dyslipidemia. Pharmacotherapy 24: 1692–713, 2004
Luo H, Imoto T, Hiji Y: Inhibitory effect of voglibose and gymnemic acid on maltose absorption in vivo. World J Gastroenterol 7: 270–274, 2001
Luo H, Wang LF, Imoto T, Hiji Y: Inhibitory effect and mechanism of acarbose combined with gymnemic acid on maltose absorption in rat intestine. World J Gastroenterol 7: 9–15, 2001
Wang LF, Luo H, Miyoshi M, Imoto T, Hiji Y, Sasaki T: Inhibitory effect of gymnemic acid on intestinal absorption of oleic acid in rats. Can J Physiol Pharmacol. 76: 1017–1023, 1998
Timar O, Sestier F, Levy E: Metabolic syndrome X: A review. Can J Cardiol. 16: 779–789, 2000
De Jonghe BC, Hajnal A, Covasa M.: Increased oral and decreased intestinal sensitivity to sucrose in obese, prediabetic CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol 288: R292–R300, 2005
Moran TH: Cholecystokinin and satiety: Current perspectives. Nutrition. 16: 858–865, 2000
Bi S, Ladenheim EE, Schwartz GJ, Moran TH: A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol Regul Integr Comp Physiol 281: R254–R260, 2001
K Kawano, T Hirashima, S Mori, Y Saitoh, M Kurosumi and T Natori: Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422–1428, 1992
Yoshida Y, Ohyanagi M, Iwasaki T: Chronological changes of alpha-adrenoceptor-mediated vascular constriction in Otsuka-Long-Evans-Tokushima fatty rats. Hypertens Res: 26: 559–567, 2003
Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H: Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension 29: 728–735, 1997
Luo H: Possible participation of NO and EDHF in the relaxation of rat intestinal circular muscle induced by Gymnema water extracts containing gymnemic acids. Yonago Igaku Zasshi 50: 22–31, 1999
Fushiki T, Kojima A, Imoto T, Inoue K, Sugimoto E: An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats. J Nutr 122: 2367–2373, 1992
Persaud SJ, Al-Majed H, Raman A, Jones PM: Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J Endocrinol 163: 207–212, 1999
Yumiko Nakamura, Yukari Tsumura, Yasuhide Tonogai and Tadashi Shibata: Fecal steroid excretion is increased in rats by oral administration of gymnemic acids contained in Gymnema sylvestre leaves. Journal of Nutrition 129: 1214–1222, 1999
Terasawa H, Miyoshi M and Toshiaki Imoto T: Effects of long-term administration of gymnema sylvestre watery-extract on variations of body weight, plasma glucose, serum triglyceride, total cholesterol and insulin in wistar fatty rats. Yonago Acta Medica 37: 117–127, 1994
Preuss HG, Bagchi D, Bagchi M, Rao CV, Dey DK, Satyanarayana S: Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes Metab 6: 171–180, 2004
Shigematsu N, Asano R, Shimosaka M, Okazaki M: Effect of administration with the extract of Gymnema sylvestre R. Br leaves on lipid metabolism in rats. Biol Pharm Bull 24: 713–717, 2001
Xie JT, Wang A, Mehendale S, Wu J, Aung HH, Dey L, Qiu S, Yuan CS: Anti-diabetic effects of Gymnema yunnanense extract. Pharmacol Res 47(4): 323–329, 2003
Stunkard AJ: Current views on obesity. Am J Med 100: 230–236, 1996
Jequier E. Pathways to obesity: Int J Obes Relat Metab Disord 260: S12–S17, 2002
Roberts SB, McCrory MA, Saltzman E: The influence of dietary composition on energy intake and body weight. J Am Coll Nutr 2002; 21: 140S–145S, 2002
Popkin BM, Paeratakul S, Zhai F, Keyou G: A review of dietary and environmental correlates of obesity with emphasis on developing countries. Obes Res 3: 145S–153S, 1995
Campbell I. The obesity epidemic: can we turn the tide?. Heart 89: 35–37, 2003
Morley JE: Neuropeptide regulation of appetite and weight. Endocr Rev 8: 256–287, 1987
Sobal J, Stunkard AJ: Socioeconomic status and obesity: A review of the literature. Psychol Bull 105: 260–275, 1989
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432, 1994
Nara Y, Gao M, Ikeda K, Sato T, Sawamura M, Kawano K, Yamori Y: Genetic analysis of non-insulin-dependent diabetes mellitus in the Otsuka Long-Evans Tokushima Fatty rat. Biochem Biophys Res Commun 241: 200–204, 1997
Schwartz, G J; Whitney, A; Skoglund, C; Castonguay, T W; Moran, T H: Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am J Physiol 277: R1144–R1151, 1999
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luo, H., Kashiwagi, A., Shibahara, T. et al. Decreased bodyweight without rebound and regulated lipoprotein metabolism by gymnemate in genetic multifactor syndrome animal. Mol Cell Biochem 299, 93–98 (2007). https://doi.org/10.1007/s11010-005-9049-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9049-7